Shandong Jiejing Group showcased its innovative seaweed active ingredients at CPHI Shanghai
Leveraging the CPHI international platform, Shandong Jiejing Group showcased its innovative achievements in brown seaweed active ingredients in Shanghai
From June 16th to 18th, 2026, the 24th CPHI China 2026 was held at the Shanghai New International Expo Centre. As a highly influential professional event covering the entire global pharmaceutical industry chain, this year's exhibition brought together over 3,600 high-quality exhibitors and more than 110,000 professional buyers from around the world. Shandong Jiejing Group (hereinafter referred to as "Jiejing Group") showcased its core marine brown seaweed active ingredient series products and innovative solutions at the exhibition, booth E5B86. With its strong scientific research capabilities and advantages across the entire industry chain, it became a focus of attention at the exhibition.
Deeply rooted in the seaweed industry, focusing on the new track of marine biomedicine
At this exhibition, Jiejing Group showcased its cutting-edge achievements in the field of marine active ingredients, including fucoxanthin, fucoidan and alginate oligosaccharide, as well as its traditional advantageous products such as sodium alginate and propylene glycol alginate.
Leveraging its proprietary core extraction technology and domestically leading large-scale production lines, Jiejing Group is committed to providing stable and efficient active ingredient solutions for the pharmaceutical and healthcare industries. Among these, fucoxanthin, a high-value active ingredient extracted from natural seaweed, has broad application prospects in pharmaceutical additives, functional health products, and cosmetics. Its industrial-scale production has effectively broken the international technological monopoly.
Technology drives quality, building a full-process quality control system
At the exhibition, the marketing and R&D team of Jiejing Group engaged in in-depth discussions with new and existing customers from home and abroad, providing detailed information on the physicochemical properties of seaweed raw materials, formulation adaptation solutions, and the standardized production quality control system throughout the entire process. As one of the earliest companies in the domestic industry to pass ISO9001 quality management system, ISO14001 environmental management system, and national pharmaceutical GMP certification, Jiejing Group has always regarded quality as its lifeline. The company is currently not only a major global producer of industrial-grade alginate, but also one of the few domestic enterprises to achieve large-scale industrial production of fucoidan and fucoxanthin.
Stay abreast of industry trends and deepen global industrial cooperation
CPHI China 2026 is not only a platform for showcasing innovative achievements, but also a window into industry trends. This year's exhibition focuses on "industry depth + cross-sector breadth," covering the entire industry chain, including pharmaceutical raw materials, natural products, and biotechnology. Jiejing Group, leveraging its comprehensive quality, environmental, and safety management system and market network covering more than 80 countries and regions in Asia, Europe, and the Americas, further achieved efficient supply and demand matching through this exhibition, accurately grasping the forefront of industry development.
